AI-powered personalized lifestyle plan to lower blood pressure
Official title: Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial
Run by National Bureau of Economic Research, Inc. · NCT07725250 · Data updated 2026-11-12
A digital health program uses AI to tailor lifestyle tips to people with hypertension and tries to help them lower their blood pressure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | National Bureau of Economic Research, Inc. Academic / other |
| Locations | 1 site (La Jolla, California) |
| Status | Recruiting |
| Started | April 10, 2026 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07725250 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Stage I–II hypertension (BP 140/90 or higher) who can make informed decisions and can participate without mobility aids.
✕Probably not a fit
Patients with pregnancy or under 18, those in care settings with high vulnerability, or those needing supplemental oxygen may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial tests a digital health tool that collects daily habit data and blood pressure readings to generate personalized lifestyle recommendations. The AI/ML system delivers tailored guidance in low- or high-intensity formats, integrated into regular care at UC San Diego Health. Outcomes will compare blood pressure changes across diverse patient groups to refine usability and effectiveness of the program.
Why it matters
Potential benefit: If successful, participants may see greater reductions in blood pressure through personalized, easy-to-use lifestyle changes.
How similar studies have gone: Prior studies using digital health and AI-driven personalization have shown promise in improving cardiovascular risk factors, though experiences vary by population and implementation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Stage I-II hypertension (average clinical readings of blood pressure over 140/90) * Adequate decisional capacity to make a choice about participating in this research study * Fully ambulatory (not requiring assistive device such as a cane, wheelchair, walker, etc.) Exclusion Criteria: * Pregnancy * Under age 18 years * Institutionalized individuals who are likely to be vulnerable * Dependent on supplemental oxygen
Where it's running
-
University of California, San Diego
La Jolla, California, United States Recruiting
Study contacts
- Principal investigator: Itzik Fadlon — National Bureau of Economic Research, Inc.
- Study coordinator: Amanda Walker
- Email: Alw038@health.ucsd.edu
- Phone: 617-588-1445
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.